Fingerprint
Dive into the research topics of 'Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically